Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Rheims

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Fundamental & Clinical Pharmacology|October 22, 2020
Is the mechanism of action of antiseizure drugs a key element in the choice of treatment?Deborah Guery, Sylvain Rheims
Expert Review of Neurotherapeutics|May 4, 2012
Retigabine for partial onset seizuresSylvain Rheims, Philippe Ryvlin
Current Opinion in Neurology|February 24, 2026
SUDEP update 2026: recent advances in experimental and clinical researchPhilippe Ryvlin, Sylvain Rheims
La Revue Du Praticien|March 24, 2011
[Epilepsy in the adult]Sylvain Rheims, Philippe Ryvlin
Presse Medicale (Paris, France : 1983)|March 12, 2018
[Management of drug-resistant epilepsy]Marine Loizon, Sylvain Rheims
Neuropsychiatric Disease and Treatment|May 30, 2013
Profile of perampanel and its potential in the treatment of partial onset seizuresSylvain Rheims, Philippe Ryvlin
Current Opinion in Neurology|February 18, 2016
Predicting epilepsy surgery outcomePhilippe Ryvlin, Sylvain Rheims
Neuropsychiatric Disease and Treatment|July 21, 2021
Clinical Management of Drug Resistant Epilepsy: A Review on Current StrategiesDeborah Guery, Sylvain Rheims
La Revue Du Praticien|January 19, 2019
[Therapeutic arsenal in adult epilepsy]Marine Loizon, Sylvain Rheims
Expert Review of Neurotherapeutics|February 13, 2009
Once-daily lamotrigine extended release for epilepsy managementSylvain Rheims, Philippe Ryvlin
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Fundamental & Clinical Pharmacology|October 22, 2020
Is the mechanism of action of antiseizure drugs a key element in the choice of treatment?Deborah Guery, Sylvain Rheims
Expert Review of Neurotherapeutics|May 4, 2012
Retigabine for partial onset seizuresSylvain Rheims, Philippe Ryvlin
Current Opinion in Neurology|February 24, 2026
SUDEP update 2026: recent advances in experimental and clinical researchPhilippe Ryvlin, Sylvain Rheims
La Revue Du Praticien|March 24, 2011
[Epilepsy in the adult]Sylvain Rheims, Philippe Ryvlin
Presse Medicale (Paris, France : 1983)|March 12, 2018
[Management of drug-resistant epilepsy]Marine Loizon, Sylvain Rheims
Neuropsychiatric Disease and Treatment|May 30, 2013
Profile of perampanel and its potential in the treatment of partial onset seizuresSylvain Rheims, Philippe Ryvlin
Current Opinion in Neurology|February 18, 2016
Predicting epilepsy surgery outcomePhilippe Ryvlin, Sylvain Rheims
Neuropsychiatric Disease and Treatment|July 21, 2021
Clinical Management of Drug Resistant Epilepsy: A Review on Current StrategiesDeborah Guery, Sylvain Rheims
La Revue Du Praticien|January 19, 2019
[Therapeutic arsenal in adult epilepsy]Marine Loizon, Sylvain Rheims
Expert Review of Neurotherapeutics|February 13, 2009
Once-daily lamotrigine extended release for epilepsy managementSylvain Rheims, Philippe Ryvlin
Pageof 18